Brief: Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From Nafld/Nash
Oct 13 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES CONFIRMS ISSUANCE OF U.S. PATENT
COVERING THE
USE OF TESAMORELIN IN THE TREATMENT OF INDIVIDUALS SUFFERING
FROM NAFLD/NASH
Source text for Eikon: ID:nGNX3SXSry
Further company coverage: TH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process